Cargando…
Detection of mixed populations of wild-type and YMDD hepatitis B variants by pyrosequencing in acutely and chronically infected patients
BACKGROUND: Lamivudine (LAM) is associated with the highest known rate of resistance mutations among nucleotide analogs used to treat chronic hepatitis B virus (HBV) infection. Despite this, LAM continues in widespread use, especially in combination therapies. The primary LAM resistance mutation (rt...
Autores principales: | Mello, Francisco C A, Lago, Bárbara V, Lewis-Ximenez, Lia L, Fernandes, Carlos A, Gomes, Selma A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3395561/ https://www.ncbi.nlm.nih.gov/pubmed/22672436 http://dx.doi.org/10.1186/1471-2180-12-96 |
Ejemplares similares
-
Compensatory variances of drug-induced hepatitis B virus YMDD mutations
por: Cai, Ying, et al.
Publicado: (2016) -
YMDD motif mutation after lamivudine therapy
por: Jazayeri, Seyed Mohammad, et al.
Publicado: (2011) -
Inflammation Pharmacological Reaction and YMDD Mutational Patterns in Lamivudine Therapeutics Hepatitis B Virus
por: Liu, Hongcan, et al.
Publicado: (2021) -
Natural YMDD motif mutations in treatment naïve patients with chronic hepatitis B in Huzhou of eastern China
por: Qian, Fuchu, et al.
Publicado: (2016) -
Detection of YMDD Motif Mutants by Oligonucleotide Chips in Lamivudine-Untreated Patients with Chronic Hepatitis B Virus Infection
por: Heo, Jeong, et al.
Publicado: (2004)